Stephen Mayo - Jul 8, 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
Veer Bhavnagri as attorney-in-fact
Stock symbol
ALLO
Transactions as of
Jul 8, 2022
Transactions value $
$0
Form type
4
Date filed
7/12/2022, 04:48 PM
Previous filing
Jun 1, 2022
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +35.3K $0.00 35.3K Jul 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to Buy) Award $0 +54.5K $0.00 54.5K Jul 8, 2022 Common Stock 54.5K $12.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. The shares subject to the stock option shall vest in a series of 36 successive equal installments measured from the date of grant.